Retired Oak Ridge, Tennessee, physician notes the downside of a class of drugs − GLP-1s − first approved for treating ...
This is just a sneak peek at the thousands of consumer insights available to CivicScience clients. Discover more data. The ...
A review of the medical records of thousands of adolescents treated for obesity found that kids who received the GLP-1 ...
GLP-1 agonists work by triggering the pancreas to produce more insulin, which reduces blood sugar levels in those with type 2 ...
Chinese insulin maker Gan & Lee Pharmaceuticals is wading into the obesity world with an injectable GLP-1 agonist that beat Novo Nordisk's Ozempic (semaglutide) at lowering glycated hemoglobin (HbA1c) ...
Researchers found that 1.4% of adolescents on weight loss medications had a suicide attempt or ideation, compared with 2.3% of children who weren’t taking the medicines. Separately, anxiety is found ...